Lyme borreliosis is a multi-systemic disease that can be caused by three different species of the Borrelia burgdorferi sensu lato complex: B. afzelii, B. garinii, and B. sensu stricto. In Europe) all three species can be found in patients with Lyme disease) where in the United States only B. burgdorferi sensu stricto plays a role in humans. Cases of Lyme borreliosis have been reported from all temperate regions of North America, Europe, and Asia. The main vector for the transfer of the organism in Europe is the tick Ixodes ricinus; in the United States primarily Ixodes scapularis and Ixodes pacificus. Ixodes develops in three stages — from larvae to nymph to adult tick. The ticks become infected by feeding on small mammals or certain birds which serve as reservoirs for Borrelia burgdorferi. In central Europe between 8–34% of 1. ricinus have been found to carry Borrelia burgdorferi.
KeywordsLyme Disease Borrelia Burgdorferi Lyme Borreliosis Adult Tick Erythema Migrans
Unable to display preview. Download preview PDF.
- Anonymus. CDC Lyme WHO-CC. http://www.cdc.gov
- Oschmann P., Kraiczy P., Halperin J., Brade V. (eds): Lyme Borreliosis and Tick-borne Encephalitis. Unimed, Bremen (1999)Google Scholar
- Paul H., Gerth H.J., Ackermann R.: Infectiousness for humans of Ixodes ricinus containing Borrelia burgdorferi. Zentralblatt fur Bakteriologie und Hygiene (A) 263:473–476 (1986)Google Scholar
- Sigal L.H., Zahradnik J.M., Lavin P., Patella S.J., Bryant G., Haselby R., Hilton E., Kunkel M., AdlerKlein D., Doherty T., Evans J., Malawista S.E., and the recombinant outer surface protein A Lyme disease vaccine study consortium: A vaccine consisting of recombinant Borrelia burgdorferi outersurface protein A to prevent Lyme disease. New England Journal of Medicine 339:216–222 (1998)PubMedCrossRefGoogle Scholar
- Steere A.C., Sikand V.K., Meurice E, Parenti D.L., Fikrig E., Schoen R.T., Nowakowski J., Schmid C.H., Laukamp S., Buscarino C., Krause D.C., and the Lyme disease vaccine study group: Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. New England Journal of Medicine 339:209–215 (1998)PubMedCrossRefGoogle Scholar